SOPHNasdaqServices-Computer Processing & Data PreparationFiscal year ends December 31
SOPHiA GENETICS SA
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 3, 2026
$6.49−0.24 (-3.57%)
Close on Oct 19, 2026
- Market cap
- $479.21M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns SOPHiA GENETICS's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
1 buys · 137 sales
Net sold $4.29M
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Generation Investment Management LLP | 6,789,560 | 10.22% | 13G (passive) amendment | Sep 30, 2024 |
| Akre Capital Management, LLC | 3,719,140 | 5.60% | 13G (passive) | Jun 20, 2025 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Ross Muken | Chief Executive Officer, Director | 870,229 | 1.27% | Sep 22, 2026 |
| Jurgi Camblong | Executive Chairman, Director | 3,435,822 | 5.02% | Sep 14, 2026 |
| George Cardoza | Chief Financial Officer | 308,318 | 0.45% | Sep 22, 2026 |
| Zhenyu Xu | Chief Scientific Officer | 552,887 | 0.81% | Sep 16, 2026 |
| Philippe Menu | Chief Medical Officer | 208,387 | 0.30% | Sep 16, 2026 |
| Well Daan Van | Chief Legal Officer | 338,884 | 0.49% | Sep 14, 2026 |
| Abhimanyu Verma | Chief Technology Officer | 172,171 | 0.25% | Aug 26, 2026 |
| Manuela Valente | Chief People Officer | 220,450 | 0.32% | Aug 21, 2026 |
| Kevin Puylaert | Chief Sales Officer | 147,948 | 0.22% | Jul 7, 2026 |
| Kathy L. Hibbs | Director | 96,992 | 0.14% | Sep 10, 2026 |
| Troy Cox | Director | 328,743 | 0.48% | Jun 22, 2026 |
| Didier Hirsch | Director | 240,220 | 0.35% | Jun 22, 2026 |
| Vincent Ossipow | Director | 522,860 | 0.76% | Jun 22, 2026 |
| Jean-Michel Cossery | Director | 206,212 | 0.30% | Jun 22, 2026 |
| Tomer Berkovitz | Director | – | – | Mar 18, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| George Cardoza Chief Financial Officer | Sep 21, 2026 | Sale(10b5-1 plan) | −774 | $8.33 | $6.45K | 308,318 |
| Ross Muken Chief Executive Officer, Director | Sep 21, 2026 | Sale(10b5-1 plan) | −422 | $8.33 | $3.52K | 670,229 |
| Zhenyu Xu Chief Scientific Officer | Sep 14, 2026 | Sale(10b5-1 plan) | −4,000 | $7.88 | $31.52K | 552,887 |
| Philippe Menu Chief Medical Officer | Sep 14, 2026 | Sale(10b5-1 plan) | −5,000 | $7.88 | $39.40K | 208,387 |
| Well Daan Van Chief Legal Officer | Sep 11, 2026 | Sale(10b5-1 plan) | −6,168 | $7.63 | $47.06K | 338,884 |
| Jurgi Camblong Executive Chairman, Director | Sep 10, 2026 | Sale(10b5-1 plan) | −8,500 | $7.66 | $65.11K | 3,435,822 |
| Kathy L. Hibbs Director | Sep 8, 2026 | Sale(10b5-1 plan) | −6,250 | $8.13 | $50.81K | 96,992 |
| Zhenyu Xu Chief Scientific Officer | Aug 27, 2026 | Sale(10b5-1 plan) | −10,000 | $8.91 | $89.10K | 556,887 |
| Philippe Menu Chief Medical Officer | Aug 25, 2026 | Sale(10b5-1 plan) | −5,000 | $8.68 | $43.40K | 213,387 |
| Kathy L. Hibbs Director | Aug 25, 2026 | Sale(10b5-1 plan) | −6,250 | $8.68 | $54.25K | 103,242 |
| Abhimanyu Verma Chief Technology Officer | Aug 24, 2026 | Sale(10b5-1 plan) | −5,000 | $8.80 | $44.00K | 172,171 |
| Zhenyu Xu Chief Scientific Officer | Aug 21, 2026 | Sale(10b5-1 plan) | −5,408 | $8.40 | $45.43K | 566,887 |
| Zhenyu Xu Chief Scientific Officer | Aug 20, 2026 | Sale(10b5-1 plan) | −4,592 | $8.41 | $38.62K | 572,295 |
| Abhimanyu Verma Chief Technology Officer | Aug 19, 2026 | Sale(10b5-1 plan) | −5,000 | $8.20 | $41.00K | 177,171 |
| Manuela Valente Chief People Officer | Aug 19, 2026 | Option exercise | +10,000 | $3.20 | $32.00K | 220,450 |
| Manuela Valente Chief People Officer | Aug 19, 2026 | Sale(10b5-1 plan) | −10,000 | $7.94 | $79.40K | 210,450 |
| Zhenyu Xu Chief Scientific Officer | Aug 19, 2026 | Sale(10b5-1 plan) | −10,000 | $7.94 | $79.40K | 576,887 |
| Zhenyu Xu Chief Scientific Officer | Aug 13, 2026 | Sale(10b5-1 plan) | −4,000 | $7.52 | $30.08K | 586,887 |
| Philippe Menu Chief Medical Officer | Aug 12, 2026 | Sale(10b5-1 plan) | −5,000 | $7.52 | $37.60K | 218,387 |
| Jurgi Camblong Executive Chairman, Director | Aug 10, 2026 | Sale(10b5-1 plan) | −8,500 | $7.61 | $64.69K | 3,444,322 |
| Abhimanyu Verma Chief Technology Officer | Aug 7, 2026 | Sale(10b5-1 plan) | −5,000 | $7.60 | $38.00K | 182,171 |
| Jurgi Camblong Executive Chairman, Director | Aug 7, 2026 | Sale(10b5-1 plan) | −20,000 | $7.23 | $144.60K | 3,452,822 |
| Zhenyu Xu Chief Scientific Officer | Aug 7, 2026 | Option exercise | +7,000 | $3.28 | $22.96K | 607,887 |
| Zhenyu Xu Chief Scientific Officer | Aug 7, 2026 | Sale(10b5-1 plan) | −7,000 | $7.02 | $49.14K | 600,887 |
| Zhenyu Xu Chief Scientific Officer | Aug 7, 2026 | Sale(10b5-1 plan) | −10,000 | $7.48 | $74.80K | 590,887 |
| Zhenyu Xu Chief Scientific Officer | Aug 5, 2026 | Sale(10b5-1 plan) | −3,000 | $7.00 | $21.00K | 600,887 |
| Zhenyu Xu Chief Scientific Officer | Aug 5, 2026 | Option exercise | +3,000 | $3.28 | $9.84K | 603,887 |
| Jurgi Camblong Executive Chairman, Director | Aug 4, 2026 | Sale(10b5-1 plan) | −20,000 | $6.92 | $138.40K | 3,472,822 |
| Abhimanyu Verma Chief Technology Officer | Aug 4, 2026 | Sale(10b5-1 plan) | −5,000 | $6.95 | $34.75K | 187,171 |
| Zhenyu Xu Chief Scientific Officer | Aug 4, 2026 | Sale(10b5-1 plan) | −10,000 | $6.92 | $69.20K | 600,887 |
| Philippe Menu Chief Medical Officer | Jul 27, 2026 | Sale(10b5-1 plan) | −5,000 | $5.66 | $28.30K | 223,387 |
| Jurgi Camblong Executive Chairman, Director | Jul 21, 2026 | Sale(10b5-1 plan) | −20,000 | $6.63 | $132.60K | 3,492,822 |
| Jurgi Camblong Executive Chairman, Director | Jul 20, 2026 | Option exercise | +4,581 | $3.16 | $14.48K | 3,517,403 |
| Jurgi Camblong Executive Chairman, Director | Jul 20, 2026 | Sale(10b5-1 plan) | −4,581 | $6.17 | $28.26K | 3,512,822 |
| Jurgi Camblong Executive Chairman, Director | Jul 20, 2026 | Sale(10b5-1 plan) | −19,800 | $6.32 | $125.14K | 3,512,822 |
| Philippe Menu Chief Medical Officer | Jul 13, 2026 | Sale(10b5-1 plan) | −5,000 | $5.70 | $28.50K | 228,387 |
| Zhenyu Xu Chief Scientific Officer | Jul 13, 2026 | Sale(10b5-1 plan) | −4,000 | $5.70 | $22.80K | 610,887 |
| Jurgi Camblong Executive Chairman, Director | Jul 10, 2026 | Sale(10b5-1 plan) | −8,500 | $5.62 | $47.77K | 3,532,622 |
| Jurgi Camblong Executive Chairman, Director | Jul 7, 2026 | Sale(10b5-1 plan) | −17,685 | $5.28 | $93.38K | 3,541,122 |
| Ross Muken Chief Executive Officer, Director | Jul 6, 2026 | Sale(10b5-1 plan) | −9,838 | $5.22 | $51.35K | 670,651 |
| Zhenyu Xu Chief Scientific Officer | Jul 6, 2026 | Sale(10b5-1 plan) | −7,393 | $5.17 | $38.22K | 614,887 |
| Jurgi Camblong Executive Chairman, Director | Jul 6, 2026 | Sale(10b5-1 plan) | −22,486 | $5.26 | $118.28K | 3,558,807 |
| George Cardoza Chief Financial Officer | Jul 6, 2026 | Sale(10b5-1 plan) | −1,592 | $5.29 | $8.42K | 309,092 |
| Manuela Valente Chief People Officer | Jul 6, 2026 | Sale(10b5-1 plan) | −4,241 | $5.05 | $21.42K | 210,450 |
| Philippe Menu Chief Medical Officer | Jul 6, 2026 | Sale(10b5-1 plan) | −7,393 | $5.16 | $38.15K | 233,387 |
| Abhimanyu Verma Chief Technology Officer | Jul 6, 2026 | Sale(10b5-1 plan) | −5,285 | $5.10 | $26.95K | 192,171 |
| Kevin Puylaert Chief Sales Officer | Jul 6, 2026 | Sale | −31 | $5.09 | $158 | 147,948 |
| Kevin Puylaert Chief Sales Officer | Jul 6, 2026 | Sale | −138 | $5.03 | $694 | 148,026 |
| Kevin Puylaert Chief Sales Officer | Jul 6, 2026 | Sale | −47 | $5.03 | $236 | 147,979 |
| Jurgi Camblong Executive Chairman, Director | Jun 30, 2026 | Option exercise | +45,419 | $3.16 | $143.52K | 3,646,562 |
| Jurgi Camblong Executive Chairman, Director | Jun 30, 2026 | Sale(10b5-1 plan) | −45,419 | $6.14 | $278.87K | 3,601,143 |
| Jurgi Camblong Executive Chairman, Director | Jun 30, 2026 | Sale(10b5-1 plan) | −19,650 | $6.02 | $118.29K | 3,581,493 |
| Jurgi Camblong Executive Chairman, Director | Jun 30, 2026 | Sale(10b5-1 plan) | −200 | $6.30 | $1.26K | 3,581,293 |
| Jurgi Camblong Executive Chairman, Director | Jun 29, 2026 | Sale(10b5-1 plan) | −18,060 | $5.87 | $106.01K | 3,601,493 |
| Jurgi Camblong Executive Chairman, Director | Jun 29, 2026 | Option exercise | +18,060 | $3.16 | $57.07K | 3,619,553 |
| Jurgi Camblong Executive Chairman, Director | Jun 29, 2026 | Sale(10b5-1 plan) | −350 | $6.00 | $2.10K | 3,601,143 |
| Jurgi Camblong Chief Executive Officer, Director | Jun 26, 2026 | Sale(10b5-1 plan) | −18,129 | $5.73 | $103.88K | 3,601,493 |
| Jurgi Camblong Chief Executive Officer, Director | Jun 26, 2026 | Option exercise | +31,940 | $3.16 | $100.93K | 3,633,433 |
| Jurgi Camblong Chief Executive Officer, Director | Jun 26, 2026 | Sale(10b5-1 plan) | −31,940 | $5.84 | $186.53K | 3,601,493 |
| Jurgi Camblong Chief Executive Officer, Director | Jun 25, 2026 | Sale(10b5-1 plan) | −1,373 | $5.70 | $7.83K | 3,619,622 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Camblong Jurgi Director, Officer | Oct 5, 2026 | 65,672 | $529.97K | Oct 5, 2026 | Restricted Stock Units |
| Cardoza George Officer | Oct 5, 2026 | 1,592 | $12.85K | Oct 5, 2026 | Restricted Stock Units |
| Valente Manuela Officer | Oct 5, 2026 | 4,240 | $34.22K | Oct 5, 2026 | Restricted Stock Units |
| Menu Philippe Officer | Oct 5, 2026 | 22,394 | $180.72K | Oct 5, 2026 | Restricted Stock Units |
| J. Muken Ross Director, Officer | Oct 5, 2026 | 9,838 | $79.39K | Oct 5, 2026 | Restricted Stock Units |
| Guido Maria Van Well Daan Officer | Oct 5, 2026 | 6,168 | $49.78K | Oct 5, 2026 | Restricted Stock Units |
| Xu Zhenyu Officer | Oct 5, 2026 | 19,394 | $156.51K | Oct 5, 2026 | Restricted Stock Units |
| Cardoza George Officer | Sep 21, 2026 | 774 | $6.34K | Sep 21, 2026 | Restricted Stock Units |
| J. Muken Ross Director, Officer | Sep 21, 2026 | 422 | $3.46K | Sep 21, 2026 | Restricted Stock Units |
| Guido Maria Van Well Daan Officer | Sep 11, 2026 | 6,168 | $46.94K | Sep 11, 2026 | Restricted Stock Units |
| Xu Zhenyu Officer | Aug 27, 2026 | 14,000 | $119.42K | Aug 27, 2026 | Founders Shares |
| L. Hibbs Kathy Director | Aug 25, 2026 | 18,750 | $158.44K | Aug 25, 2026 | Restricted Stock Units |
| Xu Zhenyu Officer | Aug 20, 2026 | 6,000 | $49.68K | Aug 20, 2026 | Founders Shares |
| Valente Manuela Officer | Aug 19, 2026 | 10,000 | $76.20K | Aug 19, 2026 | Exercise of Stock Options |
| Xu Zhenyu Officer | Aug 19, 2026 | 8,000 | $60.96K | Aug 19, 2026 | Founders Shares |